MedTrace Logo

A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults

NCT07235137 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-01-07

No results posted yet for this study

Summary

A study to learn how the study medicine called Ibuzatrelvir is taken up into the blood in healthy Chinese adults.

Conditions

  • Healthy Participant

Interventions

DRUG

Ibuzatrelvir

Ibuzatrelvir will be given by mouth to adult Chinese healthy volunteers

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-16
Primary Completion
2025-11-21
Completion
2025-11-21

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07235137 on ClinicalTrials.gov